New publication: “Mesenchymal Stromal Cells for Transplant Tolerance” from Istituto di Ricerche Farmacologiche Mario Negri IRCCS

The review “Mesenchymal Stromal Cells for Transplant Tolerance” prepared by Manuel Alfredo Podestà, Giuseppe Remuzzi and Federica Casiraghi of the Department of Molecular Medicine, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy appeared in Frontiers in Immunology on 4 June 2019.

Congratulations to the team!

DOI: 10.3389/fimmu.2019.01287

Read the entire manuscript here.

NEPHSTROM plenary meeting hosted by Azienda Ospedaliera Papa Giovanni XXIII Bergamo

The NEPHSTROM project team recently had another very successful and productive plenary meeting in Bergamo, Italy hosted by NEPHSTROM partner Azienda Ospedaliera Papa Giovanni XXIII Bergamo. The meeting began with a warm welcome by NEPHSTROM Coordinator Prof Tim O’Brien, NUI Galway and proceeded to a lively and productive discussion of NEPHSTROM’s work, with a particular focus on the ongoing clinical trial and the potential for the commercial exploitation of NEPHSTROM’s work.

International Clinical Trials Day 2019 at the CRF Galway

The HRB Clinical Research Facility Galway in Ireland hosted a public event to celebrate International Clinical Trials Day on May 20th 2019. Exhibition stands were on display and informational meetings were held throughout the day to inform the public of all areas of clinical research being undertaken at the facility.

A particular stand was dedicated to the CRF Galway’s stem cell work to inform the public of the cell therapy projects being undertaken with partners within the National University of Ireland Galway and with European partners.  NEPHSTROM was showcased here, as were the related projects VISICORT and ADIPOA-2.

Dr Veronica McInerney comments, “Great interest was expressed in this evolving therapeutic area with approximately 100 members of the public stopping by to hear about what cell therapy involves and to learn about the projects from the clinical researchers on the day.”

Dr Veronica McInerney, CRF Galway

Clinical researchers and visitors, CRF Galway

NUI Galway NEPHSTROM team celebrate 3 recent publications

Congratulations to NEPHSTROM researchers at NUI Galway who have recently published three papers:

“Allogeneic Mesenchymal Stromal Cells (MSCs) are of Comparable Efficacy to Syngeneic MSCs for Therapeutic Revascularization in C57BKSdb/db Mice Despite the Induction of Alloantibody”, A. LiewC. Baustian, D. Thomas, E. VaughanC. Sanz-NoguésM. CreaneX. ChenS. AlagesanP. OwensJ. HoranP. DockeryM. D. GriffinA. DuffyT. O’Brien. Cell Transplant. 2018 Aug;27(8):1210-1221. DOI: 10.1177/0963689718784862. Epub 2018 Jul 17. Download the pdf here.

“Effect of Sodium Glucose Co-Transporter-2 Inhibition on the Aldosterone/Renin Ratio in Type 2 Diabetes Mellitus”, Griffin TP, Islam MN, Blake L, Bell M, Griffin MD, O’Shea PM. Horm Metab Res 2019; 51:91-99. DOI: 10.1055/a-0794-7026. Epub 2018 Dec 6

“Defining reference intervals for a serum growth differentiation factor-15 (GDF-15) assay in a Caucasian population and its potential utility in diabetic kidney disease (DKD)”, Siobhan M. Hamon, Tomás P. Griffin, Md Nahidul Islam, Deirdre Wall, Matthew D. Griffin, Paula M. O’Shea, Clinical Chemistry and Laboratory Medicine (CCLM), 20180534, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, Walter de Gruyter GmbH, Berlin/Boston, 2018, DOI: https://doi.org/10.1515/cclm-2018-0534.

ISPOR 2019 award for NEPHSTROM research

NEPHSTROM-supported research by partners at Queen’s University Belfast and  Belfast Health and Social Care Trust has been identified as a semi-finalist for a Research Poster Presentation Award at ISPOR 2019 in New Orleans, USA. The research poster entitled “PUK21: RACIAL DISPARITIES IN RECORDING ANEMIA AS A COMPLICATION AMONG END-STAGE RENAL DISEASE PATIENTS” will be presented by Nga T.Q. Nguyen on 21 May 2019 at the conference. Nga is a PhD student at Queen’s University Belfast and is supervised by NEPHSTROM PIs Ciaran O’ Neill, Peter Maxwell and Michael Donnelly. At this conference, only the top 10% of accepted research abstracts, based on peer review scoring, are eligible for a research poster award. Congratulations, Nga!

ISPOR is the Professional Society for Health Economics and Outcomes Research founded in 1995 by a small group of dedicated volunteers and visionaries with the goal of serving as a catalyst for advancing the science and practice of health economics and outcomes research worldwide. ISPOR 2019 runs from May 18-22, 2019.

NEPHSTROM consortia hosted by UHBFT in Birmingham

The NEPHSTROM project team recently had another very successful and productive plenary meeting in Birmingham U.K. hosted by NEPHSTROM partner UHBFT. The meeting began with a warm welcome by NEPHSTROM Coordinator Prof Tim O’Brien, NUIG and a roundtable of introductions for any new attendees. In attendance, there were 23 delegates representing NEPHSTROM partner sites. Scientific Programme Manager Dr Grace Davey, NUIG refreshed the team by presenting the project plan and current timelines. Mark Sweetnam from partner Pintail Limited reported on administrative and project management updates including a review of deliverable and milestones and reporting requirements.

After a clinical production update from the GMP manufacturing sites, NEPHSTROM trial sponsor IRFMN updated the group on the latest status of the NEPHSTROM clinical trial. The timelines and plans for the next six months were presented and discussed in detail. Each clinical partner reported on patient recruitment numbers and future plans to do so including additional means to enhance recruitment. At this time the project is in the very exciting phase of patient enrolment and infusion and each site (Italy, U.K. and Ireland) are actively proceeding with administration of the blinded product (NEPHSTROM ORBCEL-M or placebo) to enroled patients. After lunch, QUB provided the team with a summary of what has been accomplished in the last six months and future plans in terms of the health economics aspects of NEPHSTROM. The meeting also included a review of recent dissemination and communication tasks and success stories that have been captured in the media including press releases re the trial and scientific presentations of NEPHSTROM at UK Kidney Week and the American Society of Nephrology meeting in San Diego, USA. The meeting concluded with a round-up of project tasks, publication plans and post-meeting actions.

NEPHSTROM is showcased on the CORDIS website

Journalists from the European Commission have recently reported on NEPHSTROM in order to showcase the project on the CORDIS website. CORDIS is the Community Research and Development Information Service. It is the European Commission’s primary public repository and portal to disseminate information on all EU-funded research projects and their results in the broadest sense.

The CORDIS news piece entitled “Novel therapy for diabetic kidney disease” was published on 3 January 2019 in six languages. The story appears in German, English, Spanish, French, Italian and Polish.

In addition, find the NEPHSTROM factsheet and public reports on the CORDIS website here.

 

NEPHSTROM public exhibition at Galway Science & Technology Festival 2018

NEPHSTROM Scientific Project Manager Dr Grace Davey amongst many other NUI Galway researchers participated at the Galway Science and Technology Festival Exhibition Day on Sunday, 25 November 2018. The interactive NEPHSTROM display in the Bailey Allen Hall of the National University of Ireland Galway exhibited models and props which helped to explain diabetes and its complications and future plans for cell therapy to a general audience. A set of stir tank bioreactors was on display to illustrate the technology required to produce large batches of human bone marrow-derived mesenchymal stromal cells (MSCs) for use as a cell therapy.

 

Pictured above Dr Grace Davey, NUI Galway

 

NEPHSTROM presents at American Society of Nephrology Kidney Week, San Diego

NEPHSTROM PIs Matthew Griffin of the National University of Ireland, Galway and Norberto Perico of the Istituto di Ricerche Farmacologiche Mario Negri (IRFMN) were involved in presentations at the American Society of Nephrology Kidney Week, San Diego, USA. The meeting which ran from the 23-28 October 2018 is the largest international conference for Nephrology.

Norberto Perico, MD gave an invited talk on “Mesenchymal Stem Cell Therapies in DKD: The NEPHSTROM Experience” on October 27, 2018, as part of a session entitled  “Diabetic Kidney Disease: New Tricks for Old Targets”. Prof Matthew Griffin was a moderator of the aforementioned session.

Kidney Week provided participants exciting and challenging opportunities to exchange knowledge, learn the latest scientific and medical advances, and listen to engaging and provocative discussions with leading experts in the field.

Prof. Griffin noted: “Diabetic kidney disease was a very hot topic at this year’s Kidney Week. It is clear that the Nephrology community is highly motivated to bring novel and personalised therapies into the clinical arena and to better understand their mechanisms of action in human subjects. Dr. Perico’s presentation was part of a well-attended session dedicated to novel therapeutic targets in DKD and stimulated insightful questions and discussion from audience members about the safety, efficacy and immunological effects of systemic mesenchymal stromal cell administration in people with CKD due to diabetes. The ongoing NEPHSTROM clinical trial is specifically designed to address such key questions”.